Zoon Kathryn C 4
4 · Emergent BioSolutions Inc. · Filed May 25, 2022
Insider Transaction Report
Form 4
Zoon Kathryn C
Director
Transactions
- Sale
Common Stock
2022-05-24$35.53/sh−1,996$70,918→ 12,381 total
Footnotes (2)
- [F1]Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- [F2]All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.